Economy

Lilly Raises Sales Forecast, Widening Lead in Obesity Market

Eli Lilly & Co. raised its full-year sales forecast as demand for its blockbuster obesity and diabetes drugs continues to surge, giving the drugmaker more momentum as it expands into pills and develops even more powerful weight-loss treatments.